Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Prat

Showing results (191-200 of 268) with videos related to

Pageof 27
Sort By:
Cell|December 10, 2019
Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVSChun-Cheih Chao, Cristina Gutiérrez-Vázquez, Veit Rothhammer, et al.
European Journal of Neurology|March 16, 2021
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registryHelmut Butzkueven, Tim Spelman, Dana Horakova, et al.
Neurology|August 11, 2017
Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMSJohannes Lorscheider, Vilija G Jokubaitis, Tim Spelman, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Disease-associated astrocyte epigenetic memory promotes CNS pathologyHong-Gyun Lee, Joseph M Rone, Zhaorong Li, et al.
Annals of Clinical and Translational Neurology|June 30, 2025
Cervical Spinal Cord Magnetization Transfer Ratio and Its Relationship With Clinical Outcomes in Multiple SclerosisLisa Eunyoung Lee, Julien Cohen-Adad, Irene M Vavasour, et al.
Nature Neuroscience|April 10, 2019
Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39Maisa C Takenaka, Galina Gabriely, Veit Rothhammer, et al.
Nature|August 26, 2025
Author Correction: Disease-associated astrocyte epigenetic memory promotes CNS pathologyHong-Gyun Lee, Joseph M Rone, Zhaorong Li, et al.
Nature|March 21, 2024
Disease-associated astrocyte epigenetic memory promotes CNS pathologyHong-Gyun Lee, Joseph M Rone, Zhaorong Li, et al.
Nature Neuroscience|June 15, 2019
Author Correction: Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39Maisa C Takenaka, Galina Gabriely, Veit Rothhammer, et al.
Neurology. Clinical Practice|April 23, 2016
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MSTim Spelman, Tomas Kalincik, Vilija Jokubaitis, et al.
Pageof 27

Showing results (191-200 of 268) with videos related to

Sort By:
Pageof 27
Cell|December 10, 2019
Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVSChun-Cheih Chao, Cristina Gutiérrez-Vázquez, Veit Rothhammer, et al.
European Journal of Neurology|March 16, 2021
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registryHelmut Butzkueven, Tim Spelman, Dana Horakova, et al.
Neurology|August 11, 2017
Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMSJohannes Lorscheider, Vilija G Jokubaitis, Tim Spelman, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Disease-associated astrocyte epigenetic memory promotes CNS pathologyHong-Gyun Lee, Joseph M Rone, Zhaorong Li, et al.
Annals of Clinical and Translational Neurology|June 30, 2025
Cervical Spinal Cord Magnetization Transfer Ratio and Its Relationship With Clinical Outcomes in Multiple SclerosisLisa Eunyoung Lee, Julien Cohen-Adad, Irene M Vavasour, et al.
Nature Neuroscience|April 10, 2019
Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39Maisa C Takenaka, Galina Gabriely, Veit Rothhammer, et al.
Nature|August 26, 2025
Author Correction: Disease-associated astrocyte epigenetic memory promotes CNS pathologyHong-Gyun Lee, Joseph M Rone, Zhaorong Li, et al.
Nature|March 21, 2024
Disease-associated astrocyte epigenetic memory promotes CNS pathologyHong-Gyun Lee, Joseph M Rone, Zhaorong Li, et al.
Nature Neuroscience|June 15, 2019
Author Correction: Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39Maisa C Takenaka, Galina Gabriely, Veit Rothhammer, et al.
Neurology. Clinical Practice|April 23, 2016
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MSTim Spelman, Tomas Kalincik, Vilija Jokubaitis, et al.
Pageof 27